Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
Conditions : Elderly Females; HER2 + Breast Cancer; Neoadjuvant Therapy Interventions : Drug: olaparib combined with trastuzumab and pertuzumab Sponsors : Wen-Ming Cao Recruiting
Read the full article16h agoen
You might also wanna read
Disitamab Vedotin, Tislelizumab, and S-1 Deliver High Response Rates in HER2-Overexpressing Advanced Gastric/GEJ Cancer
HER2-targeted therapy has improved outcomes in advanced gastric and gastroesophageal junction adenocarcinoma, but resistance and heterogeneo
OncoDaily·1h ago
Ribociclib Plus Aromatase Inhibitor Delays Postprogression Events in HR+/HER2− Metastatic Breast Cancer
For patients with hormone receptor-positive, HER2-negative metastatic breast cancer, endocrine therapy combined with a CDK4/6 inhibitor has
OncoDaily·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.